Coronavirus (COVID-19) Readiness
Key Biologics (A Cellero Company) is open and maintaining normal operations. To ensure that we can maintain normal operations as the spread of COVID-19 continues, we have activated our business continuity plans. Our management teams are focused on overseeing our response to the evolving situation. COVID-19 has not impacted Key Biologics’ ability to deliver any…